Skip to main content

Hospitals: Infectious Diseases

Volume 491: debated on Wednesday 22 April 2009

To ask the Secretary of State for Health what criteria his Department used in choosing the winners of the Healthcare Associated Infection Technology Innovation programme Awards; and whether each of the products commended in the awards have been reviewed by his Department's Rapid Review panel. (269295)

The Healthcare Associated Infection (HCAI) Technology Innovation Programme Awards were not part of the Rapid Review Panel (RRP) process but part of a wider programme involving innovation in general and HCAI technology innovation.

The awards categories, winners and whether they have a RRP recommendation are shown as follows.



RRP recommendation

Innovative technological concept: originating from industry with the most potential to prevent HCAI

ErgoMedica Ltd. for MedMat

RRP recommendation 2

Team or individual from the NHS or industry that has contributed in the most practical way to promoting the development and/or adoption of HCAI related technology

Blackpool, Fylde and Wyre Hospitals NHS Foundation Trust for the implementation of a new rapid MRSA PCR testing technology

Outside RRP remit

For Actual new and/or novel HCAI related product or technology likely or proven to help reduce infection

TwistDx for applying its novel DNA technology to develop a rapid, portable MRSA test

Not submitted to RRP

Innovative technological concept or new and novel product or technology offering the greatest contribution in controlling Clostridium difficile

BIOQUELL plc for its hydrogen peroxide vapour system

RRP recommendation 1

New and/or novel product or technology with the greatest contribution to enhancing the cleanliness of the hospital environment

OSPREY DEEPCLEAN steam cleaning technology.

Not submitted to RRP

All entries were reviewed and short listed by the judging panel. All short listed entries were then invited to present their product to the panel during two interview days. From the presentations and interviews the judges chose their winners.

To ask the Secretary of State for Health pursuant to the answer of 30 March 2009, Official Report, column 1223W, on hospitals: infectious diseases, for what reasons the average of all quarters of the year was not used to calculate the reduction in methicillin-resistant staphylococcus aureus; and if he will make a statement. (269713)

The October to December 2008 quarter was used because it was the most recent information available. There is a downward trend over the last three quarters, April to June 2008 being a 56 per cent. reduction, July to September 2008 a 62 per cent. reduction and October to December 2008 a 65 per cent. reduction compared to the 2003-04 quarterly average.